6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
1h ago	KIST Connects Korean Quantum Startups with IBM to Accelerate Global Commercialization
1h ago	Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes
2h ago	Faraday Future Announces Strategic Partnership Between FF AI-Robotics and Boston International Business School to Launch the BIBS–FF AI Robotics Institute, the First Industry-Driven Physical AI and Robotics Institute in the United States
3h ago	From Funan to the World Stage, Homegrown mc.2 Acquired by Global Leader Hunter Douglas After Two Decades of Consumer-Led Innovation
3h ago	BOE, UNESCO introduce Asia-Pacific Science Club Network & 2026 Science Challenge

About

Connect Biopharma Holdings Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis

Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update

Connect Biopharma Announces $20.2 Million Private Placement Financing

Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD

Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting

Recent Videos

CNTB STOCK : FRESH BREAKOUT | CONNECT BIOPHARMA STOCK

CNTB STOCK : FRESH BREAKOUT | CONNECT BIOPHARMA STOCK

May 07, 2026

Connect Biopharma Results From A Phase 3 52-Week Study In Patients With Moderate To Severe AD

Connect Biopharma Results From A Phase 3 52-Week Study In Patients With Moderate To Severe AD

Mar 31, 2026

Cómo invertir en Connect Biopharma Holdings Ltd (CNTB) paso a paso

Cómo invertir en Connect Biopharma Holdings Ltd (CNTB) paso a paso

Mar 20, 2026

Episode 130 - Barry Quart - CEO Connect Biopharma

Episode 130 - Barry Quart - CEO Connect Biopharma

Mar 16, 2026

Community Chat

Ask AI